1.2.2 The frequency of monitoring should be based on the presence and magnitude ofbiochemical changes, on the rate of CKD progression, according to the treatment ofCKD-MBD, with the use of growth hormone or kidney transplantation (Opinion). Here, GH1 is linked to chronic kidney disease.